about
Use of nonlinear mixed effect modeling for the intestinal absorption data: application to ritonavir in the rat.Development of novel diolein-niosomes for cutaneous delivery of tretinoin: influence of formulation and in vitro assessment.Impact of Undernutrition on the Pharmacokinetics and Pharmacodynamics of Anticancer Drugs: A Literature Review.Fabrication of polyelectrolyte multilayered vesicles as inhalable dry powder for lung administration of rifampicin.Bioactivity of Ceftazidime and Fluconazole Included in Polymethyl Methacrylate Bone Cement for Use in Arthroplasty.Bifunctional viscous nanovesicles co-loaded with resveratrol and gallic acid for skin protection against microbial and oxidative injuries.Improving oral bioavailability and pharmacokinetics of liposomal metformin by glycerolphosphate-chitosan microcomplexation.Inhibition of skin inflammation by baicalin ultradeformable vesicles.A dopamine transport inhibitor with markedly low abuse liability suppresses cocaine self-administration in the rat.The influence of active secretion processes on intestinal absorption of salbutamol in the rat.Pharmacokinetic models for the saturable absorption of cefuroxime axetil and saturable elimination of cefuroxime.Profile of P-glycoprotein distribution in the rat and its possible influence on the salbutamol intestinal absorption process.Fabrication of quercetin and curcumin bionanovesicles for the prevention and rapid regeneration of full-thickness skin defects on mice.The dopamine uptake inhibitor 3 alpha-[bis(4'-fluorophenyl)metoxy]-tropane reduces cocaine-induced early-gene expression, locomotor activity, and conditioned reward.Goal-directed fluid and hemodynamic therapy in major colon surgery with the pressure recording analytical method cardiac output monitor (MostCare®-PRAM®): prospective analysis of 58 patients.Effect of quercetin and resveratrol co-incorporated in liposomes against inflammatory/oxidative response associated with skin cancer.Enhancement of nortriptyline penetration through human epidermis: influence of chemical enhancers and iontophoresis.Nutriosomes: prebiotic delivery systems combining phospholipids, a soluble dextrin and curcumin to counteract intestinal oxidative stress and inflammation.Exploring the co-loading of lidocaine chemical forms in surfactant/phospholipid vesicles for improved skin delivery.Antibiotic-loaded Bone Cement as Prophylaxis in Total Joint Replacement.Nanodesign of new self-assembling core-shell gellan-transfersomes loading baicalin and in vivo evaluation of repair response in skin.A novel ultradeformable liposomes of Naringin for anti-inflammatory therapy.Levofloxacin effect on erlotinib absorption. Evaluation of the interaction in undernutrition situations through population pharmacokinetic analysis in rats.Modelling intestinal absorption of salbutamol sulphate in rats.Hydroxypropylmethylcellulose films for the ophthalmic delivery of diclofenac sodium.Animal model of undernutrition for the evaluation of drug pharmacokinetics.A preclinical study to model taurine pharmokinetics in the undernourished rat.Glycerosomes: Use of hydrogenated soy phosphatidylcholine mixture and its effect on vesicle features and diclofenac skin penetration.Pharmacokinetics and absolute bioavailability of oral cefuroxime axetil in the rat.Impact of nutritional status on the pharmacokinetics of erlotinib in rats.Investigation of Different Iontophoretic Currents Profiles for Short-Term Applications in CosmeticsChitosan–xanthan gum microparticle-based oral tablet for colon-targeted and sustained delivery of quercetinPolymeric nanospheres as strategy to increase the amount of triclosan retained in the skin: passive diffusion vs. iontophoresisDesign, characterization and in vitro evaluation of 5-aminosalicylic acid loaded N-succinyl-chitosan microparticles for colon specific deliveryA Pharmacokinetic Model for Evaluating the Impact of Hepatic and Intestinal First-Pass Loss of Saquinavir in the RatImpact of nutritional status on the oral bioavailability of leucine administered to rats as part of a standard enteral dietIn Situ Study of the Effect of Naringin, Talinolol and Protein-Energy Undernutrition on Intestinal Absorption of Saquinavir in RatsN-Succinyl-chitosan systems for 5-aminosalicylic acid colon delivery: In vivo study with TNBS-induced colitis model in ratsBioavailability and Pharmacokinetic Model for Ritonavir in the RatPopulation modelling to describe pharmacokinetics of amiodarone in rats: Relevance of plasma protein and tissue depot binding
P50
Q30993791-7A6F3C18-4C0C-444F-BDBD-C2F0B1F15CBFQ35471066-F395B5AB-B532-4B45-BA00-F736B5019AE8Q38869469-5BEF14C8-86FD-4AD3-A5D4-21027DA88EE2Q38984966-B36A943F-FA35-49EE-9DBA-A8D8176C0FFFQ40142625-91D5F840-1717-4660-8E23-9C4C6B338531Q40335040-66553469-5C47-49E7-8DC9-E1E6978EDF64Q41125054-957CA06F-E327-4040-9BE6-3C7D5334536BQ42809303-11479004-D44E-4C8E-9F3D-42B70A6B30C8Q43276178-1350F86A-8BE7-45A6-BDA2-938696EAD26DQ43662621-39B8C704-6448-4AD9-BA1C-EA0BC070AA53Q44752315-3C6C28C3-2A32-493D-A134-1BBD4A4C72F7Q44881594-239D64C8-6D99-4221-810E-8AD133AE4DD7Q45125862-2BCF7AA8-D036-4431-8178-3193D07FC9AEQ45928219-0DDDCD92-B7FD-46DB-8690-4A118ED2EDAAQ45931925-5470EAFB-FF32-416D-9D79-2750AD934B51Q46473127-D3284EB6-E2DD-4511-950C-2257C1DA180CQ46670581-A874A021-CF17-40B1-88D3-A82FC7922104Q47723451-213C1DC5-978A-496E-92B8-BDA5D08515EAQ47753207-1586FD14-D2E0-455E-983B-080C89182147Q47816072-0607E6BA-A4AB-4FA2-BD60-A9B7C7D6161BQ49720952-C912CC12-0F3C-4A3E-8BC0-F81C03C1C7F7Q50027152-7D85F70D-4D31-44BB-BF26-A9FC24555B05Q50947265-550633BC-6B88-4075-903C-54578CCD42F4Q51237572-E8F6BB27-9094-402F-9E0C-6E38EBA5D89DQ51282117-5D5F843E-6CA4-4007-9AF7-F43F8CA74E22Q51404296-F8138504-A00D-4115-9CAE-6E201BC28512Q52640971-E62722A1-0AAC-4FF7-959E-10D53E4A4CCAQ52859735-EF06652B-8E7A-45C2-B5CA-574846CC8BD9Q53907572-61E3C35F-6551-4500-B6D7-9F4D80EB3331Q54284937-E4193165-503C-4083-B9BB-0E6464ED7848Q60910723-EB0C97DF-C2C7-4029-A05E-DD241E728B00Q60929252-9D262CC0-667B-489D-8B57-39A799A8C82AQ60929289-50B3B3F0-5087-4ED2-A025-7A2D3AB1CFDCQ60929302-901501B0-583A-4291-BA05-EA065901ED96Q60929311-15415E5A-D0BB-46C7-A2B0-0A5B497CA234Q60929344-F8A4820C-55C0-444D-BE7B-B45D1E3E2410Q60929357-746BDCCD-5B20-4757-8477-99F0851E6891Q60929370-321ED17D-6522-483E-B201-C562B5C298C2Q60929419-7747F5F1-4D31-4DDB-9B68-07F086FE520EQ60929428-757A5063-A72E-4F8B-99EF-C3204AA6E727
P50
description
researcher
@en
wetenschapper
@nl
name
Amparo Nácher
@en
Nácher A
@nl
type
label
Amparo Nácher
@en
Nácher A
@nl
altLabel
Nácher A
@en
prefLabel
Amparo Nácher
@en
Nácher A
@nl
P106
P31
P496
0000-0002-1707-7966